Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 630-641

  Yaoita, Hiroyuki ^a   Ogawa, Kazuei ^a   Maehara, Kazuhira ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Infarction; Ischemia

Indexed keywords

ADENOSINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CASPASE; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE DONOR; PROTEIN BCL 2; SOMATOMEDIN C;

APOPTOSIS; CELL DEATH; CELL STRUCTURE; DNA REPAIR; ENZYME INHIBITION; GENE TARGETING; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR;

ADENOSINE; ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; ENZYME INHIBITORS; HEART; HUMANS; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROTEIN KINASE INHIBITORS;

EID: 0033980348     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00349-1     Document Type: Review

References (75)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
2. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
3. Tanaka M., Ito H., Adachi S., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
4. Itoh G., Tamura J., Suzuki M., et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol. 146:1995;1325-1331.
5. Buerke M., Murohara T., Skurk C., et al. Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92:1995;8031-8035.
6. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 184:1995;39-51.
7. Cheng W., Kajstura J., Nitahara J.A., et al. Programmed cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 226:1996;316-327.
8. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
9. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:1996;949-956.
10. Olivetti G., Quaini F., Sala R., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 28:1996;2005-2016.
11. Misao J., Hayakawa Y., Ohno M., et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512.
12. Gottlieb R.A., Groul D.L., Zhu J.Y., Engler R.L. Preconditioning in rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 97:1996;2391-2398.
13. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865.
14. Yin T., Sandhu G., Wolfgang C.D., et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 272:1997;19943-19950.
15. Saraste A., Pulkki K., Kallajoki M., et al. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
16. Long X., Boluyt M.O., Hipolito M.L., et al. P53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiomyocytes. J Clin Invest. 99:1997;2635-2643.
17. Veinot J.P., Gattinger D.A., Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol. 28:1997;485-492.
18. Kirshenbaum L.A., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
19. Bialik S., Geenen D.L., Sasson I.E., et al. Myocyte apoptosis during acute myocardial infarction in mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 100:1997;1363-1372.
20. Piot C.A., Padmanaban D., Ursell P.C., Sievers R.E., Wolfe C.L. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation. 96:1997;1598-1604.
21. Bielawska A.E., Shapiro J.P., Jiang L., et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol. 151:1997;1257-1263.
22. Li Q., Li B., Wang X., et al. Overexpression of insulin like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilatation, wall stress and cardiac hypertrophy. J Clin Invest. 100:1997;1991-1999.
23. Morishita R., Sugimoto T., Aoki M., et al. In vivo transfection of cis element 'decoy' against nuclear factor-kB binding site prevents myocardial infarction. Nat Med. 3:1997;894-899.
24. Thiemerman C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA. 94:1997;679-683.
25. Umansky S.R., Shapiro J.P., Cuenco G.M., et al. Prevention of rat neonatal cardiomyocyte apoptosis induced by stimulated in vitro ischemia and reperfusion. Cell Death Differ. 4:1997;608-616.
26. Halestrap A.P., Connern C.P., Griffiths E.J., Kerr P.M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischemia/reperfusion injury. Mol Cell Biochem. 174:1997;167-172.
27. Yang J., Liu X., Bhalla K., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
28. Enari M., Sakahira H., Yokoyama H., et al. A caspase-activated DNase that degradates DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
29. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
30. Ohno M., Takemura G., Ohno A., et al. 'Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation. Analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation. 98:1998;1422-1430.
31. Takemura G., Ohno M., Hayakawa Y., et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res. 82:1998;1130-1138.
32. Black S.C., Huang J.Q., Rezaiefar P., et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol. 30:1998;733-742.
33. Li W.G., Zaheer A., Coppey L., Oskarsson H.J. Activation of JNK in the remote myocardium after large myocardial infarction in rats. Biochem Biophy Res Commun. 246:1998;816-820.
34. Maulik N., Kagan V.E., Tyurin V.A., Das D.K. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol. 274:1998;H242-H248.
35. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
36. Yue T.L., Ma X.L., Wang X., et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res. 82:1998;166-174.
37. Vakeva A.P., Agah A., Rollins S.A., et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Role of the terminal complements and inhibition by anti-C5 therapy. Circulation. 97:1998;2259-2267.
38. Ma X.L., Kumar S., Gao F., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 99:1999;1685-1691.
39. Humphreys R.A., Haist J.V., Chakrabarti S., et al. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol. 276:1999;H749-H757.
40. Maulik N., Goswami S., Galang N., Das D.K. Differential regulation of bcl-2, AP-1 and NF-kB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett. 443:1999;331-336.
41. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
42. Okamura T., Miura T., Iwamoto H., et al. Effect of caspase-1 or caspase-3 inhibitor on infarct size and apoptotic cell death in the ischemia-reperfused rat heart (abstract). Circulation. 98:(suppl):1998;I-260.
43. Long X., Crow M.T., Lakatta E.G. ICE-related proteases are involved in hypoxia-induced apoptosis in cardiac myocytes (abstract). Circulation. 96:(suppl):1997;I-116.
44. Bialik S., Geenen D.L., Sasson I.E., et al. The caspase family of cysteine proteases mediate cardiac monocyte apoptosis during myocardial infarction (abstract). Circulation. 96:(suppl):1997;I-552.
45. Sawa Y., Bai H.Z., Suzuki K., Tsujimoto Y., Matsuda H. Overexpression of bcl-2 gene improves the myocardial tolerance to ischemia-reperfusion by preventing DNA fragmentation (abstract). Circulation. 92:(suppl):1995;I-772.
46. Kagisaki K., Sawa Y., Fukushima N., et al. Bcl-2 prevents hypoxia-reoxygenation induced cell death and DNA damage in adult rat cardiomyocytes: a evidence for endogenous myocardial protective system against ischemia-reperfusion injury (abstract). Circulation. 94:(suppl):1996;I-472.
47. Jones S.P., Girod W.G., Stassi G., et al. Cardiomyocyte apoptosis is attenuated following myocardial ischemia-reperfusion injury in transgenic mice overexpressing bcl-xl in the heart (abstract). Circulation. 98:(suppl):1998;I-15.
48. Buja L.M. Modulation of the myocardial response to ischemia. Lab Invest. 78:1998;1345-1373.
49. Majno G., Joris I. Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol. 146:1995;3-15.
50. Anversa P., Leri A., Beltrami C.A., Guerra S., Kajstura J. Myocyte death and growth in the failing heart. Lab Invest. 78:1998;767-787.
51. Didenko W., Hornsby P.J. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 135:1996;1369-1376.
52. Leri A., Claudio P.P., Li Q., et al. Stretch-mediated release of angiotension II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax ratio in the cell. J Clin Invest. 101:1998;1326-1342.
53. Matsuoka R, Ogawa K, Maruyama Y. Evidence against hypoxia-induced apoptosis in cardiomyocytes (abstract). J Mol Cell Cardiol 1999 (in press).
54. Bartling B., Holtz J., Darmer D. Contribution of myocyte apoptosis to myocardial infarction? Basic Res Cardiol. 93:1998;71-84.
55. Kanoh M., Takemura G., Misao J., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Not apoptosis but DNA repair. Circulation. 99:1999;2757-2764.
56. Condorelli G., Pisani A., Stassi G., et al. Targeted expression of CASPASE 3 in transgenic mice induces contractile dysfunction and cardiomyocyte degeneration which is prevented by bcl-xl (abstract). Circulation. 98:(suppl):1998;I-461.
57. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Circulation 1999 (Letter to the Editor, in press).
58. Vercammen D., Beyaert R., Denecker G., et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med. 187:1998;1477-1485.
59. Yamashita K., Takahashi A., Kobayashi S., et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood. 93:1999;674-685.
60. Bialik S., Cryns V., Drincic A., Srinivasan A., Kitsis R.N. Cytochrome c release from the mitochondria precedes caspase activation in apoptotic myocytes during ischemia (abstract). Circulation. 98:(suppl):1998;I-462.
61. Susin S.A., Zamzami N., Castedo M., et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 184:1996;1331-1341.
62. Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:1999;2934-2941.
63. Wang L., Ma W., Markovich R., Wen Chen J.W., Wang H.P. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor. Circ Res. 83:1998;516-522.
64. Bellas R.E., FitzGerald M.J., Fausto N., Sonenshein G.E. Inhibition of NF-kB activity induces apoptosis in murine hepatocytes. Am J Pathol. 151:1997;891-896.
65. Maulik N., Engelman R.M., Rousou J.A., et al. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene BCL 2 (abstract). Circulation. 98:(suppl):1998;I-611.
66. Massoudy P., Zahler S., Kuppat C., et al. Cardioprotection by cyclosporin A in experimental ischemia and reperfusion: evidence for a nitric oxide-dependent mechanism mediated by endothelin. J Mol Cell Cardiol. 29:1997;535-544.
67. Chen S.J., Bradley M.E., Lee T.C. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: Modulation by calcium-regulated proteases and protein kinases. Mol Cell Biochem. 178:1998;141-149.
68. + channels. Circ Res. 81:1997;1072-1082.
69. Kim Y.M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 84:1999;253-256.
70. Pierzchalski P., Reiss K., Cheng W., et al. P53 induces myocyte apoptosis via activation of the renin-angiotensin system. Exp Cell Res. 234:1997;57-65.
71. Leri A., Claudio P.P., Li Q., et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the bcl-2-to-bax ratio in the cell. J Clin Invest. 101:1998;1326-1342.
72. Holz J. Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction. Basic Res Cardiol. 93:(suppl 2):1998;92-100.
73. Daviet L., Horiuchi M., Hayashida W., et al. Antagonistic actions of type-1 and -2 angiotensin II receptors on rat cardiomyocyte apoptosis (abstract). Circulation. 98:(suppl):1998;I-741.
74. Mahaffey K.W., Puma J.A., Barbagelata A., et al. Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial (abstract). Circulation. 96:(suppl):1997;I-206.
75. Haunstetter A., Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease. Cardiovasc Res. 82:1998;1111-1129.